🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 1 first-in-human single ascending dose study will be a randomize...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2015-08
Trial ID
NCT02531815
Treatments Being Tested
This is a phase 1, first in human, randomized, double-blind, placebo-contro...
Status
Completed
Location
Frontage Clinical Research Center
Start Date
2023-04-17
Trial ID
NCT05724797
This is a randomized, placebo-controlled, multiple dose escalation study to...
Status
Completed
Location
Multiple Locations
Start Date
2015-03
Trial ID
NCT03006159
The purpose of this study is to examine the safety and tolerability of HFB3...
Status
Completed
Location
Huashan Hospital
Start Date
2021-05-09
Trial ID
NCT05275660
A safety study of KAN-101 in patients with celiac disease. The study has tw...
Status
Completed
Location
Anaheim Clinical Trials
Start Date
2020-01-21
Trial ID
NCT04248855
The purpose of this study is to determine whether NNZ-2566 is safe and effe...
Status
Completed
Location
University of South Alabama
Start Date
2010-04
Trial ID
NCT00805818
This is a Phase 1 study to assess the the safety, tolerability and pharmaco...
Status
Completed
Location
Research Site
Start Date
2022-04-04
Trial ID
NCT05351047
Treatments Being Tested
This is a randomized, placebo-controlled, double-blind, 3-way crossover pha...
Status
Completed
Location
Research Site
Start Date
2017-09-06
Trial ID
NCT03258515
Treatments Being Tested
The main purpose of this study is to assess how well LY3971297 is tolerated...
Status
Recruiting
Location
Henry Ford Health System
Start Date
2026-08-11
Trial ID
NCT07547540
Despite risk reduction counseling, some individuals in HIV vaccine trials o...
Status
Completed
Location
Univ of Alabama at Birmingham
Start Date
2002-04
Trial ID
NCT00029913
Treatments Being Tested